Efficacy and safety of ixekizumab in a phase III, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS)
一项针对中重度斑块状银屑病患儿的 III 期随机、双盲、安慰剂对照研究评估了 ixekizumab 的疗效和安全性 (IXORA-PEDS)
期刊:British Journal of Dermatology
影响因子:9.6
doi:10.1111/bjd.19147
Paller, A S; Seyger, M M B; Alejandro Magariños, G; Bagel, J; Pinter, A; Cather, J; Keller, S; Rodriguez Capriles, C; Gontijo Lima, R; Gallo, G; Little, C A; Edson-Heredia, E; Li, L; Xu, W; Papp, K